img

Global Tumor Necrosis Factor Alpha Inhibitors Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Tumor Necrosis Factor Alpha Inhibitors Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

The tumor necrosis factor alpha (TNF-a) inhibitors represent one of the major treatment methods for inflammatory diseases. Globally, this drug class is known to be the most successful drugs in the overall pharmaceutical industry. Several conditions such as inflammations, rheumatoid arthritis (RA), inflammatory bowel disease (IBD), and seronegative spondyloarthropathies, can be treated with the help of these drugs.
Tumor Necrosis Factor Alpha Inhibitors report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Tumor Necrosis Factor Alpha Inhibitors market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Medicine and Scientific Research are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Tumor Necrosis Factor Alpha Inhibitors industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Tumor Necrosis Factor Alpha Inhibitors key manufacturers include GlaxoSmithKline, Sanofi, Novartis, AstraZeneca, AbbVie, LG Life Sciences, Janssen Biotech, AryoGen Pharmed and Momenta Pharmaceuticals, etc. GlaxoSmithKline, Sanofi, Novartis are top 3 players and held % sales share in total in 2022.
Tumor Necrosis Factor Alpha Inhibitors can be divided into Humira, Enbrel, Remicade and Others, etc. Humira is the mainstream product in the market, accounting for % sales share globally in 2022.
Tumor Necrosis Factor Alpha Inhibitors is widely used in various fields, such as Medicine, Scientific Research and Others,, etc. Medicine provides greatest supports to the Tumor Necrosis Factor Alpha Inhibitors industry development. In 2022, global % sales of Tumor Necrosis Factor Alpha Inhibitors went into Medicine filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Tumor Necrosis Factor Alpha Inhibitors market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


GlaxoSmithKline
Sanofi
Novartis
AstraZeneca
AbbVie
LG Life Sciences
Janssen Biotech
AryoGen Pharmed
Momenta Pharmaceuticals
HanAll Biopharma
Zydus Cadila
Segment by Type
Humira
Enbrel
Remicade
Others

Segment by Application


Medicine
Scientific Research
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Tumor Necrosis Factor Alpha Inhibitors market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Tumor Necrosis Factor Alpha Inhibitors, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Tumor Necrosis Factor Alpha Inhibitors industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Tumor Necrosis Factor Alpha Inhibitors in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Tumor Necrosis Factor Alpha Inhibitors introduction, etc. Tumor Necrosis Factor Alpha Inhibitors Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Tumor Necrosis Factor Alpha Inhibitors market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Tumor Necrosis Factor Alpha Inhibitors Market Overview
1.1 Tumor Necrosis Factor Alpha Inhibitors Product Overview
1.2 Tumor Necrosis Factor Alpha Inhibitors Market Segment by Type
1.2.1 Humira
1.2.2 Enbrel
1.2.3 Remicade
1.2.4 Others
1.3 Global Tumor Necrosis Factor Alpha Inhibitors Market Size by Type
1.3.1 Global Tumor Necrosis Factor Alpha Inhibitors Market Size Overview by Type (2018-2034)
1.3.2 Global Tumor Necrosis Factor Alpha Inhibitors Historic Market Size Review by Type (2018-2024)
1.3.3 Global Tumor Necrosis Factor Alpha Inhibitors Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Tumor Necrosis Factor Alpha Inhibitors Sales Breakdown by Type (2018-2024)
1.4.2 Europe Tumor Necrosis Factor Alpha Inhibitors Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Tumor Necrosis Factor Alpha Inhibitors Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Tumor Necrosis Factor Alpha Inhibitors Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Tumor Necrosis Factor Alpha Inhibitors Sales Breakdown by Type (2018-2024)
2 Global Tumor Necrosis Factor Alpha Inhibitors Market Competition by Company
2.1 Global Top Players by Tumor Necrosis Factor Alpha Inhibitors Sales (2018-2024)
2.2 Global Top Players by Tumor Necrosis Factor Alpha Inhibitors Revenue (2018-2024)
2.3 Global Top Players by Tumor Necrosis Factor Alpha Inhibitors Price (2018-2024)
2.4 Global Top Manufacturers Tumor Necrosis Factor Alpha Inhibitors Manufacturing Base Distribution, Sales Area, Product Type
2.5 Tumor Necrosis Factor Alpha Inhibitors Market Competitive Situation and Trends
2.5.1 Tumor Necrosis Factor Alpha Inhibitors Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Tumor Necrosis Factor Alpha Inhibitors Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tumor Necrosis Factor Alpha Inhibitors as of 2022)
2.7 Date of Key Manufacturers Enter into Tumor Necrosis Factor Alpha Inhibitors Market
2.8 Key Manufacturers Tumor Necrosis Factor Alpha Inhibitors Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Tumor Necrosis Factor Alpha Inhibitors Status and Outlook by Region
3.1 Global Tumor Necrosis Factor Alpha Inhibitors Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Tumor Necrosis Factor Alpha Inhibitors Historic Market Size by Region
3.2.1 Global Tumor Necrosis Factor Alpha Inhibitors Sales in Volume by Region (2018-2024)
3.2.2 Global Tumor Necrosis Factor Alpha Inhibitors Sales in Value by Region (2018-2024)
3.2.3 Global Tumor Necrosis Factor Alpha Inhibitors Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Tumor Necrosis Factor Alpha Inhibitors Forecasted Market Size by Region
3.3.1 Global Tumor Necrosis Factor Alpha Inhibitors Sales in Volume by Region (2024-2034)
3.3.2 Global Tumor Necrosis Factor Alpha Inhibitors Sales in Value by Region (2024-2034)
3.3.3 Global Tumor Necrosis Factor Alpha Inhibitors Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Tumor Necrosis Factor Alpha Inhibitors by Application
4.1 Tumor Necrosis Factor Alpha Inhibitors Market Segment by Application
4.1.1 Medicine
4.1.2 Scientific Research
4.1.3 Others
4.2 Global Tumor Necrosis Factor Alpha Inhibitors Market Size by Application
4.2.1 Global Tumor Necrosis Factor Alpha Inhibitors Market Size Overview by Application (2018-2034)
4.2.2 Global Tumor Necrosis Factor Alpha Inhibitors Historic Market Size Review by Application (2018-2024)
4.2.3 Global Tumor Necrosis Factor Alpha Inhibitors Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Tumor Necrosis Factor Alpha Inhibitors Sales Breakdown by Application (2018-2024)
4.3.2 Europe Tumor Necrosis Factor Alpha Inhibitors Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Tumor Necrosis Factor Alpha Inhibitors Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Tumor Necrosis Factor Alpha Inhibitors Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Tumor Necrosis Factor Alpha Inhibitors Sales Breakdown by Application (2018-2024)
5 North America Tumor Necrosis Factor Alpha Inhibitors by Country
5.1 North America Tumor Necrosis Factor Alpha Inhibitors Historic Market Size by Country
5.1.1 North America Tumor Necrosis Factor Alpha Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Tumor Necrosis Factor Alpha Inhibitors Sales in Volume by Country (2018-2024)
5.1.3 North America Tumor Necrosis Factor Alpha Inhibitors Sales in Value by Country (2018-2024)
5.2 North America Tumor Necrosis Factor Alpha Inhibitors Forecasted Market Size by Country
5.2.1 North America Tumor Necrosis Factor Alpha Inhibitors Sales in Volume by Country (2024-2034)
5.2.2 North America Tumor Necrosis Factor Alpha Inhibitors Sales in Value by Country (2024-2034)
6 Europe Tumor Necrosis Factor Alpha Inhibitors by Country
6.1 Europe Tumor Necrosis Factor Alpha Inhibitors Historic Market Size by Country
6.1.1 Europe Tumor Necrosis Factor Alpha Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Tumor Necrosis Factor Alpha Inhibitors Sales in Volume by Country (2018-2024)
6.1.3 Europe Tumor Necrosis Factor Alpha Inhibitors Sales in Value by Country (2018-2024)
6.2 Europe Tumor Necrosis Factor Alpha Inhibitors Forecasted Market Size by Country
6.2.1 Europe Tumor Necrosis Factor Alpha Inhibitors Sales in Volume by Country (2024-2034)
6.2.2 Europe Tumor Necrosis Factor Alpha Inhibitors Sales in Value by Country (2024-2034)
7 Asia-Pacific Tumor Necrosis Factor Alpha Inhibitors by Region
7.1 Asia-Pacific Tumor Necrosis Factor Alpha Inhibitors Historic Market Size by Region
7.1.1 Asia-Pacific Tumor Necrosis Factor Alpha Inhibitors Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Tumor Necrosis Factor Alpha Inhibitors Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Tumor Necrosis Factor Alpha Inhibitors Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Tumor Necrosis Factor Alpha Inhibitors Forecasted Market Size by Region
7.2.1 Asia-Pacific Tumor Necrosis Factor Alpha Inhibitors Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Tumor Necrosis Factor Alpha Inhibitors Sales in Value by Region (2024-2034)
8 Latin America Tumor Necrosis Factor Alpha Inhibitors by Country
8.1 Latin America Tumor Necrosis Factor Alpha Inhibitors Historic Market Size by Country
8.1.1 Latin America Tumor Necrosis Factor Alpha Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Tumor Necrosis Factor Alpha Inhibitors Sales in Volume by Country (2018-2024)
8.1.3 Latin America Tumor Necrosis Factor Alpha Inhibitors Sales in Value by Country (2018-2024)
8.2 Latin America Tumor Necrosis Factor Alpha Inhibitors Forecasted Market Size by Country
8.2.1 Latin America Tumor Necrosis Factor Alpha Inhibitors Sales in Volume by Country (2024-2034)
8.2.2 Latin America Tumor Necrosis Factor Alpha Inhibitors Sales in Value by Country (2024-2034)
9 Middle East and Africa Tumor Necrosis Factor Alpha Inhibitors by Country
9.1 Middle East and Africa Tumor Necrosis Factor Alpha Inhibitors Historic Market Size by Country
9.1.1 Middle East and Africa Tumor Necrosis Factor Alpha Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Tumor Necrosis Factor Alpha Inhibitors Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Tumor Necrosis Factor Alpha Inhibitors Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Tumor Necrosis Factor Alpha Inhibitors Forecasted Market Size by Country
9.2.1 Middle East and Africa Tumor Necrosis Factor Alpha Inhibitors Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Tumor Necrosis Factor Alpha Inhibitors Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 GlaxoSmithKline
10.1.1 GlaxoSmithKline Company Information
10.1.2 GlaxoSmithKline Introduction and Business Overview
10.1.3 GlaxoSmithKline Tumor Necrosis Factor Alpha Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.1.4 GlaxoSmithKline Tumor Necrosis Factor Alpha Inhibitors Products Offered
10.1.5 GlaxoSmithKline Recent Development
10.2 Sanofi
10.2.1 Sanofi Company Information
10.2.2 Sanofi Introduction and Business Overview
10.2.3 Sanofi Tumor Necrosis Factor Alpha Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Sanofi Tumor Necrosis Factor Alpha Inhibitors Products Offered
10.2.5 Sanofi Recent Development
10.3 Novartis
10.3.1 Novartis Company Information
10.3.2 Novartis Introduction and Business Overview
10.3.3 Novartis Tumor Necrosis Factor Alpha Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Novartis Tumor Necrosis Factor Alpha Inhibitors Products Offered
10.3.5 Novartis Recent Development
10.4 AstraZeneca
10.4.1 AstraZeneca Company Information
10.4.2 AstraZeneca Introduction and Business Overview
10.4.3 AstraZeneca Tumor Necrosis Factor Alpha Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.4.4 AstraZeneca Tumor Necrosis Factor Alpha Inhibitors Products Offered
10.4.5 AstraZeneca Recent Development
10.5 AbbVie
10.5.1 AbbVie Company Information
10.5.2 AbbVie Introduction and Business Overview
10.5.3 AbbVie Tumor Necrosis Factor Alpha Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.5.4 AbbVie Tumor Necrosis Factor Alpha Inhibitors Products Offered
10.5.5 AbbVie Recent Development
10.6 LG Life Sciences
10.6.1 LG Life Sciences Company Information
10.6.2 LG Life Sciences Introduction and Business Overview
10.6.3 LG Life Sciences Tumor Necrosis Factor Alpha Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.6.4 LG Life Sciences Tumor Necrosis Factor Alpha Inhibitors Products Offered
10.6.5 LG Life Sciences Recent Development
10.7 Janssen Biotech
10.7.1 Janssen Biotech Company Information
10.7.2 Janssen Biotech Introduction and Business Overview
10.7.3 Janssen Biotech Tumor Necrosis Factor Alpha Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Janssen Biotech Tumor Necrosis Factor Alpha Inhibitors Products Offered
10.7.5 Janssen Biotech Recent Development
10.8 AryoGen Pharmed
10.8.1 AryoGen Pharmed Company Information
10.8.2 AryoGen Pharmed Introduction and Business Overview
10.8.3 AryoGen Pharmed Tumor Necrosis Factor Alpha Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.8.4 AryoGen Pharmed Tumor Necrosis Factor Alpha Inhibitors Products Offered
10.8.5 AryoGen Pharmed Recent Development
10.9 Momenta Pharmaceuticals
10.9.1 Momenta Pharmaceuticals Company Information
10.9.2 Momenta Pharmaceuticals Introduction and Business Overview
10.9.3 Momenta Pharmaceuticals Tumor Necrosis Factor Alpha Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Momenta Pharmaceuticals Tumor Necrosis Factor Alpha Inhibitors Products Offered
10.9.5 Momenta Pharmaceuticals Recent Development
10.10 HanAll Biopharma
10.10.1 HanAll Biopharma Company Information
10.10.2 HanAll Biopharma Introduction and Business Overview
10.10.3 HanAll Biopharma Tumor Necrosis Factor Alpha Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.10.4 HanAll Biopharma Tumor Necrosis Factor Alpha Inhibitors Products Offered
10.10.5 HanAll Biopharma Recent Development
10.11 Zydus Cadila
10.11.1 Zydus Cadila Company Information
10.11.2 Zydus Cadila Introduction and Business Overview
10.11.3 Zydus Cadila Tumor Necrosis Factor Alpha Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Zydus Cadila Tumor Necrosis Factor Alpha Inhibitors Products Offered
10.11.5 Zydus Cadila Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Tumor Necrosis Factor Alpha Inhibitors Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Tumor Necrosis Factor Alpha Inhibitors Industrial Chain Analysis
11.4 Tumor Necrosis Factor Alpha Inhibitors Market Dynamics
11.4.1 Tumor Necrosis Factor Alpha Inhibitors Industry Trends
11.4.2 Tumor Necrosis Factor Alpha Inhibitors Market Drivers
11.4.3 Tumor Necrosis Factor Alpha Inhibitors Market Challenges
11.4.4 Tumor Necrosis Factor Alpha Inhibitors Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Tumor Necrosis Factor Alpha Inhibitors Distributors
12.3 Tumor Necrosis Factor Alpha Inhibitors Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Humira
Table 2. Major Company of Enbrel
Table 3. Major Company of Remicade
Table 4. Major Company of Others
Table 5. Global Tumor Necrosis Factor Alpha Inhibitors Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Tumor Necrosis Factor Alpha Inhibitors Sales by Type (2018-2024) & (K Pcs)
Table 7. Global Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Tumor Necrosis Factor Alpha Inhibitors Sales by Type (2018-2024) & (US& Million)
Table 9. Global Tumor Necrosis Factor Alpha Inhibitors Market Share in Value by Type (2018-2024)
Table 10. Global Tumor Necrosis Factor Alpha Inhibitors Price by Type (2018-2024) & (USD/Pcs)
Table 11. Global Tumor Necrosis Factor Alpha Inhibitors Sales by Type (2024-2034) & (K Pcs)
Table 12. Global Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Tumor Necrosis Factor Alpha Inhibitors Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Value by Type (2024-2034)
Table 15. Global Tumor Necrosis Factor Alpha Inhibitors Price by Type (2024-2034) & (USD/Pcs)
Table 16. North America Tumor Necrosis Factor Alpha Inhibitors Sales by Type (2018-2024) & (K Pcs)
Table 17. North America Tumor Necrosis Factor Alpha Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Tumor Necrosis Factor Alpha Inhibitors Sales (K Pcs) by Type (2018-2024)
Table 19. Europe Tumor Necrosis Factor Alpha Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Tumor Necrosis Factor Alpha Inhibitors Sales (K Pcs) by Type (2018-2024)
Table 21. Asia-Pacific Tumor Necrosis Factor Alpha Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Tumor Necrosis Factor Alpha Inhibitors Sales (K Pcs) by Type (2018-2024)
Table 23. Latin America Tumor Necrosis Factor Alpha Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Tumor Necrosis Factor Alpha Inhibitors Sales (K Pcs) by Type (2018-2024)
Table 25. Middle East and Africa Tumor Necrosis Factor Alpha Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Tumor Necrosis Factor Alpha Inhibitors Sales by Company (2018-2024) & (K Pcs)
Table 27. Global Tumor Necrosis Factor Alpha Inhibitors Sales Share by Company (2018-2024)
Table 28. Global Tumor Necrosis Factor Alpha Inhibitors Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Tumor Necrosis Factor Alpha Inhibitors Revenue Share by Company (2018-2024)
Table 30. Global Market Tumor Necrosis Factor Alpha Inhibitors Price by Company (2018-2024) & (USD/Pcs)
Table 31. Global Tumor Necrosis Factor Alpha Inhibitors Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Tumor Necrosis Factor Alpha Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tumor Necrosis Factor Alpha Inhibitors as of 2022)
Table 34. Date of Key Manufacturers Enter into Tumor Necrosis Factor Alpha Inhibitors Market
Table 35. Key Manufacturers Tumor Necrosis Factor Alpha Inhibitors Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Tumor Necrosis Factor Alpha Inhibitors Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Tumor Necrosis Factor Alpha Inhibitors Sales by Region (2018-2024) & (K Pcs)
Table 39. Global Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Tumor Necrosis Factor Alpha Inhibitors Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Value by Region (2018-2024)
Table 42. Global Tumor Necrosis Factor Alpha Inhibitors Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 43. Global Tumor Necrosis Factor Alpha Inhibitors Sales by Region (2024-2034) & (K Pcs)
Table 44. Global Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Tumor Necrosis Factor Alpha Inhibitors Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Value by Region (2024-2034)
Table 47. Global Tumor Necrosis Factor Alpha Inhibitors Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 48. Global Tumor Necrosis Factor Alpha Inhibitors Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Tumor Necrosis Factor Alpha Inhibitors Sales by Application (2018-2024) & (K Pcs)
Table 50. Global Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Tumor Necrosis Factor Alpha Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Value by Application (2018-2024)
Table 53. Global Tumor Necrosis Factor Alpha Inhibitors Price by Application (2018-2024) & (USD/Pcs)
Table 54. Global Tumor Necrosis Factor Alpha Inhibitors Sales by Application (2024-2034) & (K Pcs)
Table 55. Global Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Tumor Necrosis Factor Alpha Inhibitors Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Value by Application (2024-2034)
Table 58. Global Tumor Necrosis Factor Alpha Inhibitors Price by Application (2024-2034) & (USD/Pcs)
Table 59. North America Tumor Necrosis Factor Alpha Inhibitors Sales by Application (2018-2024) (K Pcs)
Table 60. North America Tumor Necrosis Factor Alpha Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Tumor Necrosis Factor Alpha Inhibitors Sales by Application (2018-2024) (K Pcs)
Table 62. Europe Tumor Necrosis Factor Alpha Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Tumor Necrosis Factor Alpha Inhibitors Sales by Application (2018-2024) (K Pcs)
Table 64. Asia-Pacific Tumor Necrosis Factor Alpha Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Tumor Necrosis Factor Alpha Inhibitors Sales by Application (2018-2024) (K Pcs)
Table 66. Latin America Tumor Necrosis Factor Alpha Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Tumor Necrosis Factor Alpha Inhibitors Sales by Application (2018-2024) (K Pcs)
Table 68. Middle East and Africa Tumor Necrosis Factor Alpha Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Tumor Necrosis Factor Alpha Inhibitors Sales by Country (2018-2024) & (K Pcs)
Table 70. North America Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Tumor Necrosis Factor Alpha Inhibitors Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Value by Country (2018-2024)
Table 73. North America Tumor Necrosis Factor Alpha Inhibitors Sales by Country (2024-2034) & (K Pcs)
Table 74. North America Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Tumor Necrosis Factor Alpha Inhibitors Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Tumor Necrosis Factor Alpha Inhibitors Sales by Country (2018-2024) & (K Pcs)
Table 78. Europe Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Tumor Necrosis Factor Alpha Inhibitors Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Tumor Necrosis Factor Alpha Inhibitors Sales by Country (2024-2034) & (K Pcs)
Table 82. Europe Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Tumor Necrosis Factor Alpha Inhibitors Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Tumor Necrosis Factor Alpha Inhibitors Sales by Region (2018-2024) & (K Pcs)
Table 86. Asia-Pacific Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Tumor Necrosis Factor Alpha Inhibitors Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Tumor Necrosis Factor Alpha Inhibitors Sales by Region (2024-2034) & (K Pcs)
Table 90. Asia-Pacific Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Tumor Necrosis Factor Alpha Inhibitors Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Tumor Necrosis Factor Alpha Inhibitors Sales by Country (2018-2024) & (K Pcs)
Table 94. Latin America Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Tumor Necrosis Factor Alpha Inhibitors Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Tumor Necrosis Factor Alpha Inhibitors Sales by Country (2024-2034) & (K Pcs)
Table 98. Latin America Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Tumor Necrosis Factor Alpha Inhibitors Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Tumor Necrosis Factor Alpha Inhibitors Sales by Country (2018-2024) & (K Pcs)
Table 102. Middle East and Africa Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Tumor Necrosis Factor Alpha Inhibitors Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Tumor Necrosis Factor Alpha Inhibitors Sales by Country (2024-2034) & (K Pcs)
Table 106. Middle East and Africa Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Tumor Necrosis Factor Alpha Inhibitors Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Value by Country (2024-2034)
Table 109. GlaxoSmithKline Company Information
Table 110. GlaxoSmithKline Introduction and Business Overview
Table 111. GlaxoSmithKline Tumor Necrosis Factor Alpha Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 112. GlaxoSmithKline Tumor Necrosis Factor Alpha Inhibitors Product
Table 113. GlaxoSmithKline Recent Development
Table 114. Sanofi Company Information
Table 115. Sanofi Introduction and Business Overview
Table 116. Sanofi Tumor Necrosis Factor Alpha Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 117. Sanofi Tumor Necrosis Factor Alpha Inhibitors Product
Table 118. Sanofi Recent Development
Table 119. Novartis Company Information
Table 120. Novartis Introduction and Business Overview
Table 121. Novartis Tumor Necrosis Factor Alpha Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 122. Novartis Tumor Necrosis Factor Alpha Inhibitors Product
Table 123. Novartis Recent Development
Table 124. AstraZeneca Company Information
Table 125. AstraZeneca Introduction and Business Overview
Table 126. AstraZeneca Tumor Necrosis Factor Alpha Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 127. AstraZeneca Tumor Necrosis Factor Alpha Inhibitors Product
Table 128. AstraZeneca Recent Development
Table 129. AbbVie Company Information
Table 130. AbbVie Introduction and Business Overview
Table 131. AbbVie Tumor Necrosis Factor Alpha Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 132. AbbVie Tumor Necrosis Factor Alpha Inhibitors Product
Table 133. AbbVie Recent Development
Table 134. LG Life Sciences Company Information
Table 135. LG Life Sciences Introduction and Business Overview
Table 136. LG Life Sciences Tumor Necrosis Factor Alpha Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 137. LG Life Sciences Tumor Necrosis Factor Alpha Inhibitors Product
Table 138. LG Life Sciences Recent Development
Table 139. Janssen Biotech Company Information
Table 140. Janssen Biotech Introduction and Business Overview
Table 141. Janssen Biotech Tumor Necrosis Factor Alpha Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 142. Janssen Biotech Tumor Necrosis Factor Alpha Inhibitors Product
Table 143. Janssen Biotech Recent Development
Table 144. AryoGen Pharmed Company Information
Table 145. AryoGen Pharmed Introduction and Business Overview
Table 146. AryoGen Pharmed Tumor Necrosis Factor Alpha Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 147. AryoGen Pharmed Tumor Necrosis Factor Alpha Inhibitors Product
Table 148. AryoGen Pharmed Recent Development
Table 149. Momenta Pharmaceuticals Company Information
Table 150. Momenta Pharmaceuticals Introduction and Business Overview
Table 151. Momenta Pharmaceuticals Tumor Necrosis Factor Alpha Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 152. Momenta Pharmaceuticals Tumor Necrosis Factor Alpha Inhibitors Product
Table 153. Momenta Pharmaceuticals Recent Development
Table 154. HanAll Biopharma Company Information
Table 155. HanAll Biopharma Introduction and Business Overview
Table 156. HanAll Biopharma Tumor Necrosis Factor Alpha Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 157. HanAll Biopharma Tumor Necrosis Factor Alpha Inhibitors Product
Table 158. HanAll Biopharma Recent Development
Table 159. Zydus Cadila Company Information
Table 160. Zydus Cadila Introduction and Business Overview
Table 161. Zydus Cadila Tumor Necrosis Factor Alpha Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 162. Zydus Cadila Tumor Necrosis Factor Alpha Inhibitors Product
Table 163. Zydus Cadila Recent Development
Table 164. Key Raw Materials Lists
Table 165. Raw Materials Key Suppliers Lists
Table 166. Tumor Necrosis Factor Alpha Inhibitors Market Trends
Table 167. Tumor Necrosis Factor Alpha Inhibitors Market Drivers
Table 168. Tumor Necrosis Factor Alpha Inhibitors Market Challenges
Table 169. Tumor Necrosis Factor Alpha Inhibitors Market Restraints
Table 170. Tumor Necrosis Factor Alpha Inhibitors Distributors List
Table 171. Tumor Necrosis Factor Alpha Inhibitors Downstream Customers
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Tumor Necrosis Factor Alpha Inhibitors Product Picture
Figure 2. Global Tumor Necrosis Factor Alpha Inhibitors Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Tumor Necrosis Factor Alpha Inhibitors Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Tumor Necrosis Factor Alpha Inhibitors Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of Humira
Figure 6. Global Humira Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of Enbrel
Figure 8. Global Enbrel Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of Remicade
Figure 10. Global Remicade Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Global Tumor Necrosis Factor Alpha Inhibitors Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Tumor Necrosis Factor Alpha Inhibitors Sales Market Share by Type in 2022 & 2034
Figure 15. North America Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Volume by Type in 2022
Figure 16. North America Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Value by Type in 2022
Figure 17. Europe Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Volume by Type in 2022
Figure 18. Europe Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Value by Type in 2022
Figure 21. Latin America Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Tumor Necrosis Factor Alpha Inhibitors Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Tumor Necrosis Factor Alpha Inhibitors Revenue in 2022
Figure 27. Tumor Necrosis Factor Alpha Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Medicine
Figure 29. Global Medicine Sales YoY Growth (2018-2034) & (K Pcs)
Figure 30. Product Picture of Scientific Research
Figure 31. Global Scientific Research Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Product Picture of Others
Figure 33. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Global Tumor Necrosis Factor Alpha Inhibitors Sales by Application (2018-2034) & (US$ Million)
Figure 35. Global Tumor Necrosis Factor Alpha Inhibitors Sales Market Share by Application in 2022 & 2034
Figure 36. North America Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Volume by Application in 2022
Figure 37. North America Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Value by Application in 2022
Figure 38. Europe Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Volume by Application in 2022
Figure 39. Europe Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Value by Application in 2022
Figure 42. Latin America Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Tumor Necrosis Factor Alpha Inhibitors Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Tumor Necrosis Factor Alpha Inhibitors Manufacturing Cost Structure
Figure 47. Tumor Necrosis Factor Alpha Inhibitors Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries